A detailed history of Wcm Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wcm Investment Management, LLC holds 4,077,797 shares of NVO stock, worth $552 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
4,077,797
Previous 4,220,198 3.37%
Holding current value
$552 Million
Previous $437 Million 19.93%
% of portfolio
1.48%
Previous 1.5%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$102.11 - $135.92 $14.5 Million - $19.4 Million
-142,401 Reduced 3.37%
4,077,797 $524 Million
Q4 2023

Jan 29, 2024

SELL
$87.78 - $105.45 $203 Million - $243 Million
-2,308,713 Reduced 35.36%
4,220,198 $437 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $278 Million - $611 Million
3,061,251 Added 88.28%
6,528,911 $594 Million
Q2 2023

Jul 14, 2023

SELL
$155.98 - $172.65 $5.42 Million - $5.99 Million
-34,722 Reduced 0.99%
3,467,660 $561 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $10.4 Million - $12.5 Million
-78,344 Reduced 2.19%
3,502,382 $557 Million
Q4 2022

Feb 06, 2023

SELL
$102.55 - $135.33 $19.1 Million - $25.2 Million
-186,257 Reduced 4.94%
3,580,726 $485 Million
Q3 2022

Oct 18, 2022

SELL
$95.28 - $116.93 $7.91 Million - $9.71 Million
-83,070 Reduced 2.16%
3,766,983 $378 Million
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $103 Million - $122 Million
999,342 Added 35.06%
3,850,053 $424 Million
Q1 2022

May 06, 2022

BUY
$93.1 - $112.54 $34 Million - $41.1 Million
365,146 Added 14.69%
2,850,711 $317 Million
Q4 2021

Jan 26, 2022

BUY
$95.88 - $117.08 $238 Million - $291 Million
2,485,565 New
2,485,565 $278 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.